Han Y - Search Results

1

Lasso-Cox interpretable model of AFP-negative hepatocellular carcinoma.

Li H, Zhou C, Wang C, Li B, Song Y, Yang B, Zhang Y, Li X, Rao M, Zhang J, Su K, He K, Han Y. Li H, et al. Among authors: han y. Clin Transl Oncol. 2025 Jan;27(1):309-318. doi: 10.1007/s12094-024-03588-0. Epub 2024 Jul 4. Clin Transl Oncol. 2025. PMID: 38965191

2

MicroRNA-183 promotes migration and invasion of CD133(+)/CD326(+) lung adenocarcinoma initiating cells via PTPN4 inhibition.

Zhu C, Deng X, Wu J, Zhang J, Yang H, Fu S, Zhang Y, Han Y, Zou Y, Chen Z, Lin S. Zhu C, et al. Among authors: han y. Tumour Biol. 2016 Aug;37(8):11289-97. doi: 10.1007/s13277-016-4955-8. Epub 2016 Mar 7. Tumour Biol. 2016. PMID: 26951513

3

Dosimetric analysis of rib interference of the CTV during interstitial brachytherapy of lung tumors.

Yang B, Sun X, Pang H, Shi X, Tang T, Zhang G, Chen R, Zhang J, Wu H, Lin S, Wen Q, Han Y, Wu J. Yang B, et al. Among authors: han y. J Contemp Brachytherapy. 2017 Dec;9(6):566-571. doi: 10.5114/jcb.2017.72359. Epub 2017 Dec 30. J Contemp Brachytherapy. 2017. PMID: 29441102 Free PMC article.

4

Role of Exosomes in Immune Microenvironment of Hepatocellular Carcinoma.

Chen X, Chi H, Zhao X, Pan R, Wei Y, Han Y. Chen X, et al. Among authors: han y. J Oncol. 2022 Jan 28;2022:2521025. doi: 10.1155/2022/2521025. eCollection 2022. J Oncol. 2022. PMID: 35126514 Free PMC article. Review.

5

Clinical efficacy and safety of external radiotherapy combined with sorafenib in the treatment of hepatocellular carcinoma: a systematic review and meta-analysis.

Chen J, He K, Han Y, Guo L, Su K, Wu Z. Chen J, et al. Among authors: han y. Ann Hepatol. 2022 Jul-Aug;27(4):100710. doi: 10.1016/j.aohep.2022.100710. Epub 2022 Apr 14. Ann Hepatol. 2022. PMID: 35430357 Free article. Review.

6

PD-L1 expression on circulating tumor cells can be a predictive biomarker to PD-1 inhibitors combined with radiotherapy and antiangiogenic therapy in advanced hepatocellular carcinoma.

Su K, Guo L, He K, Rao M, Zhang J, Yang X, Huang W, Gu T, Xu K, Liu Y, Wang J, Chen J, Wu Z, Hu L, Zeng H, Li H, Tong J, Li X, Yang Y, Liu H, Xu Y, Tan Z, Tang X, Feng X, Chen S, Yang B, Jin H, Zhu L, Li B, Han Y. Su K, et al. Among authors: han y. Front Oncol. 2022 Aug 2;12:873830. doi: 10.3389/fonc.2022.873830. eCollection 2022. Front Oncol. 2022. PMID: 35982979 Free PMC article.

7

PD-1 inhibitors plus anti-angiogenic therapy with or without intensity-modulated radiotherapy for advanced hepatocellular carcinoma: A propensity score matching study.

Su K, Guo L, Ma W, Wang J, Xie Y, Rao M, Zhang J, Li X, Wen L, Li B, Yang X, Song Y, Huang W, Chi H, Gu T, Xu K, Liu Y, Chen J, Wu Z, Jiang Y, Li H, Zeng H, Wang P, Feng X, Chen S, Yang B, Jin H, He K, Han Y. Su K, et al. Among authors: han y. Front Immunol. 2022 Sep 23;13:972503. doi: 10.3389/fimmu.2022.972503. eCollection 2022. Front Immunol. 2022. PMID: 36211350 Free PMC article.

8

External radiotherapy combined with sorafenib has better efficacy in unresectable hepatocellular carcinoma: a systematic review and meta-analysis.

Li H, Wu Z, Chen J, Su K, Guo L, Xu K, Gu T, Jiang Y, Wang P, Zeng H, Chi H, He K, Han Y. Li H, et al. Among authors: han y. Clin Exp Med. 2023 Sep;23(5):1537-1549. doi: 10.1007/s10238-022-00972-4. Epub 2022 Dec 10. Clin Exp Med. 2023. PMID: 36495367 Free PMC article. Review.

9

Evaluation of Lactate Dehydrogenase and Alkaline Phosphatase as Predictive Biomarkers in the Prognosis of Hepatocellular Carcinoma and Development of a New Nomogram.

Su K, Huang W, Li X, Xu K, Gu T, Liu Y, Song J, Qian K, Xu Y, Zeng H, Yang Y, Guo L, Han Y. Su K, et al. Among authors: han y. J Hepatocell Carcinoma. 2023 Jan 14;10:69-79. doi: 10.2147/JHC.S398632. eCollection 2023. J Hepatocell Carcinoma. 2023. PMID: 36685113 Free PMC article.

10

Comparison of the efficacy and safety of selective internal radiotherapy and sorafenib alone or combined for hepatocellular carcinoma: a systematic review and Bayesian network meta-analysis.

Zeng H, Zhou C, Chen X, Hu L, Su K, Guo L, Han Y. Zeng H, et al. Among authors: han y. Clin Exp Med. 2023 Oct;23(6):2141-2150. doi: 10.1007/s10238-023-00997-3. Epub 2023 Feb 3. Clin Exp Med. 2023. PMID: 36737488 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

28,270 results

Search Page

Filters